ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,962.33
      -0.39%
      US Tech 100
      20,418.80
      -0.35%
      Dow Jones
      43,820.54
      -0.31%
      Brent Oil
      72.32
      0.63%
      Bitcoin
      89,595.29
      -1.07%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Omeros Corporation (OMER)

      7. Omeros Corporation (OMER) News

      Omeros Corporation

      Omeros Corporation (OMER)

      Omer Spa
      6.1412
      1.95
      ( 46.57% )
      Updated: 14:05:13
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      OMER News

      Official News Only

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      22 hours ago
      OMER (46.57%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      22 hours ago
      OMER (46.57%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      August 07 2024
      OMER (46.57%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 07 2024
      OMER (46.57%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 12 2024
      OMER (46.57%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      OMER (46.57%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      OMER (46.57%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      OMER (46.57%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      OMER (46.57%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 07 2024
      OMER (46.57%)

      OMER Discussion

      View Posts
      TrendTrade2016 TrendTrade2016 4 hours ago
      OMER MONSTER PLAY OF THE DAY
      👍️0
      Monksdream Monksdream 1 year ago
      OMER new 52=week low
      Then bounce
      👍️0
      shurtha2000 shurtha2000 1 year ago
      $341M cash and $12M recievables
      👍️0
      starkd748 starkd748 2 years ago
      Gap filled 6s 7s next top
      👍️0
      Roadtojourney Roadtojourney 2 years ago
      With the type of news this should have been above 5 not sure whats wrong here?
      👍️0
      starkd748 starkd748 2 years ago
      3.20 gap must fill now
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      OMER $200M PAYMENT
      👍️0
      makinezmoney makinezmoney 2 years ago
      $OMER: She back on fire now............ sheeeshhhhhhhhhhhhhh


      Go baby goooooooooo.......... $3 breaker upside




      GO $OMER
      👍️0
      starkd748 starkd748 2 years ago
      Weeeeeeee
      👍️0
      starkd748 starkd748 2 years ago
      We get some 5s I'm backing up the truck
      👍️0
      starkd748 starkd748 2 years ago
      Was a good trade but it's been done since 7s
      👍️0
      starkd748 starkd748 2 years ago
      Weeeeee
      👍️0
      starkd748 starkd748 2 years ago
      Weeeeeeeeeeeee
      👍️0
      starkd748 starkd748 2 years ago
      Yesss
      👍️0
      starkd748 starkd748 2 years ago
      Looking good
      👍️0
      starkd748 starkd748 2 years ago
      Weeeeee
      👍️0
      starkd748 starkd748 2 years ago
      Yesss
      👍️0
      starkd748 starkd748 2 years ago
      Bounced off the low 3s time to load
      👍️0
      starkd748 starkd748 2 years ago
      Maybe an A B C ... 2.17 might coming
      👍️0
      starkd748 starkd748 2 years ago
      Not ready yet
      👍️0
      starkd748 starkd748 2 years ago
      I like this at a certain fib level hehehe
      👍️0
      bandit007 bandit007 2 years ago
      Great day here! $OMER
      👍️0
      bandit007 bandit007 2 years ago
      Breaking out!
      👍️0
      bandit007 bandit007 2 years ago
      Looking good here. Steady climb
      👍️0
      bandit007 bandit007 2 years ago
      Looking good here. Steady climb
      👍️0
      Scott 75 Scott 75 3 years ago
      Wow! Thanks for sharing. I can't believe with all that going for it and the price is so beaten down.
      👍️0
      Nefyn Nefyn 3 years ago
      So what happens to OMER…a public company with tons of cash and no business operations?
      👍️0
      JackAskSlap JackAskSlap 3 years ago
      Bahhh Bahhh

      gonna do this all day long
      👍️0
      JackAskSlap JackAskSlap 3 years ago
      another round for the apes Lets GO !!
      👍️0
      JackAskSlap JackAskSlap 3 years ago
      Glad I'm just a robot no emotions needed
      👍️0
      JackAskSlap JackAskSlap 3 years ago
      Fk with BB My new addiction
      👍️0
      JackAskSlap JackAskSlap 3 years ago
      IN now I'm gonna tick flip this POS to death
      👍️0
      JackAskSlap JackAskSlap 3 years ago
      Trying for the baseline
      no holds barred..
      👍️0
      Jess070283 Jess070283 3 years ago
      Load it up!$$$
      👍️0
      TheGreenReaper TheGreenReaper 3 years ago
      OMER$$$$
      👍️0
      Golden Cross Golden Cross 3 years ago
      $14 Targeting
      👍️0
      crudeoil24 crudeoil24 3 years ago
      59M trading float. Huge news out >
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Shorts feeling the heat!!!!! >
      👍️0
      crudeoil24 crudeoil24 3 years ago
      >>>>> GANGBUSTERS <<<<< $$$$$

      OMER
      👍️0
      crudeoil24 crudeoil24 3 years ago
      OMER > That is a sweet revenue deal. OMER heading to $20.00+
      $125 million upfront payment and $200 million on achievement of commercial milestone
      Royalties of 50% on U.S. net sales until the earlier of either January 1, 2025 or payment of the $200-million milestone, after which royalties adjust to 30% of U.S. net sales
      Royalties of 15% on ex-U.S. net sales
      OMIDRIA to become a premier product in Rayner’s ophthalmology franchise
      In addition to acquiring the OMIDRIA commercial organization, including the current OMIDRIA sales force, Rayner plans to further expand its U.S. and ex-U.S. sales forces
      👍️0
      TheFinalCD TheFinalCD 3 years ago
      https://ih.advfn.com/stock-market/NASDAQ/omeros-OMER/stock-news/86711139/omeros-announces-agreement-to-sell-omidria-franch
      👍️0
      Frankestin Frankestin 3 years ago
      Here are the 5!
      Very interesting if it goes under!
      I would be tempted to open the position now!
      👍️0
      Frankestin Frankestin 3 years ago
      Someone says 5 ... will it get there?
      I would like to enter but of course they spend a lot on research and development... and for sell
      👍️0
      Frankestin Frankestin 3 years ago
      ooOOoo
      I take a handful these days!
      👍️0
      Termite7 Termite7 3 years ago
      Buying opportunity???
      👍️0
      frugalNorwegian frugalNorwegian 3 years ago
      I created a page on my site talking about OMER. Let me know if I am missing any nuggets. Thanks.

      https://frugalnorwegian.com/omer

      Summary: This company is a prime candidate for a buyout if FDA approval is given.
      👍️0
      Dr_Thorfin Dr_Thorfin 3 years ago
      If one is worried about fda's delay, Check out @alanrobertross message on StockTwits http://stocktwits.com/alanrobertross/message/333077805
      👍️0
      umiak umiak 4 years ago
      Tute ownership up to 78% been hovering around 50% for years. 20% short
      👍️0
      umiak umiak 4 years ago
      Not new news but I like the smart reporting style:
      Omeros's Biologics License Application for Blood Vessel Damage Treatment Candidate Accepted for Priority Review by FDA

      1/19/21, 8:06 AM
      10:06 AM EST, 01/19/2021 (MT Newswires) -- Omeros (OMER) said Tuesday its biologics license application for narsoplimab, a potential treatment for transplant-associated thrombotic microangiopathy, has been accepted for priority review by the US Food and Drug Administration.

      Thrombotic microangiopathy is characterized by a pattern of damage in the small blood vessels.

      The FDA has set the Prescription Drug User Fee Act action date on July 17.
      👍️0
      umiak umiak 4 years ago
      Have you looked at NLST? Short story:

      *google signed a NDA with NLST to use their seminal technology
      *google was bad even lied to court
      *they lost their appeal
      *google let date to file with scotus pass
      *now one way or another they must pay
      *one way to pay--google's case and settlement with ADT(eye opening)
      *another way to pay-- Centripetal v Cisco (cisco was bad for 3 yrs
      google is on the hook for 11 yrs)
      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160597164
      *estimate to file to lift stay Q1 2021
      *bought dips as low as .48 keep adding
      *yahoo board and ihub board are bullish
      lots of speculation but also good info.
      *there are active cases with other companies Sk-hynic recently lost
      on 2 parts of patent 907
      *scheduled markman for infringement of (NLST)patents 218 and 595 3/9/2021
      trial, if defendants choose, 12/2021
      *it is a popping year for NLST they have been chasing google in court for 11 yrs, google will have to settle.
      👍️0

      Your Recent History

      NASDAQ
      OMER
      Omeros
      Delayed Upgrade Clock